GlobalSpace Technologies Limited (BOM:540654)
India · Delayed Price · Currency is INR 24.09
-0.05 (-0.21%)
At close: Jul 31, 2026
GlobalSpace Technologies Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 514.69 | 514.69 | 430.46 | 290.48 | 193.38 | 132.89 |
Revenue Growth | 19.57% | 19.57% | 48.19% | 50.22% | 45.52% | -50.94% |
Gross Profit Gross Profit Growth | 139.13 | 139.13 | 148.06 | 92.04 | 78.78 | 102.16 |
Operating Income Operating Income Growth | 28.36 | 28.36 | 14.2 | 18.01 | 25.33 | 24.68 |
Net Income Net Income Growth | 28.52 | 28.52 | -19.99 | -35.31 | 5.2 | 5.54 |
Earnings Per Share EPS Growth | 0.79 | 0.79 | -0.58 | -1.84 | 0.45 | 0.48 |
EPS Growth | - | - | - | - | -5.53% | -90.28% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Global Global Growth | 330.14 | 330.14 | - | - | - | - |
Innopharm Innopharm Growth | 185.56 | 185.56 | - | - | - | - |
Inter Segment Transfers Inter Segment Transfers Growth | -1 | -1 | - | - | - | - |
Providing Technology Enabled Solutions and Allied Activities Providing Technology Enabled Solutions and Allied Activities Growth | - | - | 430.46 | 290.48 | 193.38 | 132.89 |
Total Total Growth | 514.69 | 514.69 | 430.46 | 290.48 | 193.38 | 132.89 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 1.52 | 1.52 | 2.86 | 0.06 | 0.06 | 0.31 |
Total Debt Total Debt Growth | 32.94 | 32.94 | 96.87 | 125.78 | 237 | 281.43 |
Net Cash (Debt) Net Cash Growth | -31.42 | -31.42 | -94.01 | -125.72 | -236.93 | -281.12 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.87 | -0.87 | -2.74 | -6.56 | -20.68 | -24.54 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 218.3 | 218.3 | 78.91 | -104.87 | 44.68 | -23.49 |
Capital Expenditures CapEx Growth | -146.86 | -146.86 | -41.91 | -38.55 | -7.35 | -145.29 |
Free Cash Flow Free Cash Flow Growth | 71.44 | 71.44 | 37 | -143.42 | 37.33 | -168.78 |
Free Cash Flow Growth | 93.08% | 93.08% | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 27.03% | 27.03% | 34.40% | 31.69% | 40.74% | 76.88% |
Operating Margin | 5.51% | 5.51% | 3.30% | 6.20% | 13.10% | 18.57% |
Pretax Margin | 3.79% | 3.79% | -5.63% | -13.12% | 2.57% | 7.01% |
Profit Margin | 5.54% | 5.54% | -4.64% | -12.16% | 2.69% | 4.17% |
FCF Margin | 13.88% | 13.88% | 8.60% | -49.37% | 19.30% | -127.01% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 30.44 | 20.22 | - | - | 66.71 | 105.03 |
P/FCF Ratio | 11.59 | 8.07 | 15.89 | - | 9.29 | - |
PS Ratio | 1.61 | 1.12 | 1.37 | 2.92 | 1.79 | 4.38 |